-
Financial Impact of Dementia Care on Thai Households: A Multicenter Study of Informal Care Costs and Contributing Factors
Sep 9, 2025, 16:22 PM -
Qualitative Exit Interviews in Charcot-Marie-Tooth Type-2 Sorbitol Dehydrogenase (CMT-SORD) Deficiency
Sep 9, 2025, 16:22 PM -
Developing Best Practice for Generative AI in Health Economic Evaluation: Evidence From a Systematic Review and Stakeholder Engagement
Sep 9, 2025, 16:22 PM -
Overall Survival With Second-Generation Androgen-Receptor Signaling Inhibitors in Patients With Metastatic Castration Resistant Prostate Cancer: An Umbrella Review
Sep 9, 2025, 16:22 PM -
Activity of the French Economic and Public Health Evaluation Committee (CEESP): Retrospective of 10 Years of Economic Assessment on Health Products
Sep 9, 2025, 16:22 PM -
Psychometric Validation of the Mucopolysaccharidosis Health Assessment Questionnaire (MPS-HAQ) for Mucopolysaccharidosis IVA
Sep 9, 2025, 16:22 PM -
Costs and Number Needed to Treat (NNT) to Achieve Improvements With C5 Inhibitors in Generalized Myasthenia Gravis From the Japanese Healthcare Perspective: A Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
Detection of a Novel Safety Signal for Atorvastatin Potential Association With Hilar Lymphadenopathy Using FAERS Disproportionality Analysis and Molecular Docking
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Patient-Reported Outcomes (PROs) in Asthma Biologic Late-Phase Studies and Approved Labels: Implications for Entry and Product Differentiation
Sep 9, 2025, 16:22 PM -
Survey of Depression Literacy and Help-Seeking Behavior Among Secondary School Students
Sep 9, 2025, 16:22 PM -
Optimizing Workforce Efficiency and Reducing Waiting Lists Through Remote Monitoring in Obstructive Sleep Apnea (OSA) Care in NHS
Sep 9, 2025, 16:22 PM -
Exploring the Use and Perception of Patient-Reported Outcome Evidence Among Cardiologists and Patients With Heart Failure
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Evaluation of Blinatumomab Use in the Measurable Residual Disease-Negative Remission State to Treat Adults With Philadelphia-Chromosome–Negative B-cell Acute Lymphoblastic Leukemia in France
Sep 9, 2025, 16:22 PM -
The Clinical and Economic Impact of the Introduction of Emicizumab as Prophylactic Treatment for Hemophilia A Patients in Greece
Sep 9, 2025, 16:22 PM -
Use of RWE in HTA Submissions: A Systematic Review of Case Studies Across Three HTA Agencies Reveals Continued Concerns Around Internal Validity and Unmeasured Confounding
Sep 9, 2025, 16:22 PM -
What Counts? Exploring Stakeholder Perspectives on the Value of Guiding Criteria for Prioritizing Public Funding of Health Technologies
Sep 9, 2025, 16:22 PM -
Economic and Clinical Impact of Advanced Therapies in Moderate-to-Severe Rheumatoid Arthritis in Spain: CIARA Study
Sep 9, 2025, 16:22 PM -
Assessing Public Health and Economic Benefits of Nirsevimab or RSVpreF for Preventing RSV-Related Outcomes in Japanese Infants
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Once-Weekly and Once-Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Clinical Trials
Sep 9, 2025, 16:22 PM -
Clinical Evidence Quality in Appraisals of Drugs for Rare Diseases in England and Germany
Sep 9, 2025, 16:22 PM
